Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | FAAH | O00519 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GMNN | O75496 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | CETP | P11597 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.41 |
| ▸ | CCR6 | P51684 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | UBE2N | P61088 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14288365 | 1.00 | MEN1 (0.42) | MEN1KMT2AFAAHTP53CYP1A2 | |
| SCHEMBL13991599 | 1.00 | MEN1 (0.42) | MEN1KMT2AFAAHTP53CYP1A2 | |
| SCHEMBL721174 | 0.97 | MEN1 (0.42) | MEN1KMT2AFAAHTP53CYP1A2 | |
| SCHEMBL721173 | 0.97 | MEN1 (0.42) | MEN1KMT2AFAAHTP53CYP1A2 | |
| SCHEMBL26835765 | 0.95 | KDM4E (0.46) | CYP3A4SOAT1LMNAALDH1A1ALOX15 | |
| SCHEMBL26858557 | 0.95 | KDM4E (0.46) | CYP3A4SOAT1LMNAALDH1A1ALOX15 | |
| SCHEMBL26835758 | 0.95 | KDM4E (0.46) | CYP3A4SOAT1LMNAALDH1A1ALOX15 | |
| SCHEMBL26835759 | 0.95 | KDM4E (0.46) | CYP3A4SOAT1LMNAALDH1A1ALOX15 | |
| SCHEMBL31285101 | 0.95 | KDM4E (0.46) | CYP3A4SOAT1LMNAALDH1A1ALOX15 | |
| SCHEMBL26835769 | 0.94 | KDM4E (0.45) | CYP3A4SOAT1LMNAALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4223886-B1 | COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA | GENFIT (FR) | 2024-10-02 | — | — | EP | disclosed |
| EP-4223886-A2 | COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA | Genfit (FR) | 2023-08-09 | — | — | EP | disclosed |
| US-20220186313-A1 | COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA | GENFIT (FR) | 2022-06-16 | — | — | US | disclosed |
| US-9358300-B2 | Transfection reagents | Life Technologies Corporation (US) | 2016-06-07 | — | — | US | disclosed |
| US-20150190522-A1 | TRANSFECTION REAGENTS | LIFE TECHNOLOGIES CORP (US) | 2015-07-09 | — | — | US | disclosed |
| US-8785200-B2 | Transfection reagents | Life Technologies Corporation (US) | 2014-07-22 | — | — | US | disclosed |
| US-7173154-B2 | Transfection reagents | INVITROGEN CORP. (US) | 2007-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150190522-A1 | TRANSFECTION REAGENTS | CPS1, PHAX, HNRNPH3 | MEN1 2562/4885KMT2A 1358/4885FAAH 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.